東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Neuroendocrine tumors- Diagnosis." ]

切換: 標籤 | MARC模式 | ISBD

Neuroendocrine neoplasia management ...

Beretta, Giordano.

FindBook

Google Book

Amazon

博客來

Neuroendocrine neoplasia management = new approaches for diagnosis and treatment /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Neuroendocrine neoplasia management/ edited by Giordano Beretta ... [et al.].
其他題名:	new approaches for diagnosis and treatment /
其他作者:	Beretta, Giordano.
出版者:	Cham :Springer International Publishing : : 2021.,
面頁冊數:	xiv, 331 p. :ill., digital ;24 cm.
內容註:	Part-1: General. History of Neuroendocrine Neoplasia -- Epidemiology of neuroendocrine neoplasms. Part-2: Diagnosis. New concepts in patholog -- Molecular Biology of Neuroendocrine Tumors -- Circulating biochemical markers of gastro-entero-pancreatic (GEP) neuroendocrine neoplasms (NENs) -- Advances in diagnostic imaging. Part-3: New Approaches for Treatment. Treatment of NET related symptoms -- New Surgical Strategies -- New approaches in medical therapies -- Loco-regional Therapies of NEN -- Radioreceptor therapy -- NETs of the lung -- Part-4: Treatment of NETs From Different Organ Origin. Gastric Neuroendocrine Tumors -- Treatment of Pancreatic Neurendocrine Tumors -- Treatment of intestinal NETs (including appendix) -- Treatment of NETs from rare origin -- Neuroendocrine Neoplasms with Peculiar Biology and Features: MEN1, MEN2A, MEN2B, MEN4, VHL, NF1. Part-5: NETs with Peculiar Biology and Feature. Mixed Neuroendocrine and Non-Neuroendocrine Neoplasms ( Mi NEN) -- Merkel Cell Carcinoma -- Therapy in poorly differentiated neuroendocrine neoplasms (NEN G3) -- Conclusion:NENs management today looking at the future.
Contained By:	Springer Nature eBook
標題:	Neuroendocrine tumors - Diagnosis. -
電子資源:	https://doi.org/10.1007/978-3-030-72830-4
ISBN:	9783030728304

Neuroendocrine neoplasia management = new approaches for diagnosis and treatment /
Neuroendocrine neoplasia managementnew approaches for diagnosis and treatment /[electronic resource] :edited by Giordano Beretta ... [et al.]. - Cham :Springer International Publishing :2021. - xiv, 331 p. :ill., digital ;24 cm.

Part-1: General. History of Neuroendocrine Neoplasia -- Epidemiology of neuroendocrine neoplasms. Part-2: Diagnosis. New concepts in patholog -- Molecular Biology of Neuroendocrine Tumors -- Circulating biochemical markers of gastro-entero-pancreatic (GEP) neuroendocrine neoplasms (NENs) -- Advances in diagnostic imaging. Part-3: New Approaches for Treatment. Treatment of NET related symptoms -- New Surgical Strategies -- New approaches in medical therapies -- Loco-regional Therapies of NEN -- Radioreceptor therapy -- NETs of the lung -- Part-4: Treatment of NETs From Different Organ Origin. Gastric Neuroendocrine Tumors -- Treatment of Pancreatic Neurendocrine Tumors -- Treatment of intestinal NETs (including appendix) -- Treatment of NETs from rare origin -- Neuroendocrine Neoplasms with Peculiar Biology and Features: MEN1, MEN2A, MEN2B, MEN4, VHL, NF1. Part-5: NETs with Peculiar Biology and Feature. Mixed Neuroendocrine and Non-Neuroendocrine Neoplasms ( Mi NEN) -- Merkel Cell Carcinoma -- Therapy in poorly differentiated neuroendocrine neoplasms (NEN G3) -- Conclusion:NENs management today looking at the future.

This book provides the most recent update on the management of neuroendocrine neoplasia (NEN), a term covering all tumors of various organs and/or with a particular histology, including MEN (multiple endocrine neoplasia) related tumors, MiNEN (mixed neuroendocrine-non-neuroendocrine neoplasms), NEC (neuroendocrine carcinoma) and Merkel's carcinoma. NENs are heterogeneous in their biology, clinical presentation and prognosis, showing a great variability in aggressiveness and therapy response. As a result, their treatment is based on a large spectrum of options. The standard therapies are surgery in early disease, various loco-regional procedures in certain conditions and mostly of a palliative nature in metastatic disease. At present, thanks to our increased understanding of molecular signaling pathways, several pharmacological approaches can be used in patients with advanced NENs. Somatostatin analogs display both anti-tumor effects and symptom control. Novel peptide-radio-receptor treatment (PRRT) is used in patients with well differentiated tumors. The agents targeting angiogenesis and/or PI3K/AKT/mTOR pathway, alone or in combination with analogues, have provided encouraging results in advanced disease. The first part of the book focuses on the history, epidemiology and the most relevant scientific achievements, covering the discoveries in genetic and molecular biology, the endoscopic techniques with guided biopsy, and the metabolic imaging with hybrid PET/CT and MRI/CT. It particularly highlights the emerging strategies in therapy, surgery and mini-invasive surgery as well as loco-regional and systemic treatments, including targeted therapy and/or biological therapies. The second part then explores the management of NENs of various anatomical origins and/or with peculiar biology. It describes the range of the current options and the most relevant results from the clinical trials. This informative book provides valuable insights for all those interested in the management of neuroendocrine neoplasia.

ISBN: 9783030728304

Standard No.: 10.1007/978-3-030-72830-4doiSubjects--Topical Terms:

2153596
Neuroendocrine tumors
--Diagnosis.

LC Class. No.: RC280.E55 / N48 2021

Dewey Class. No.: 616.9944

Neuroendocrine neoplasia management = new approaches for diagnosis and treatment /
LDR:04190nmm a2200325 a 4500 001 2242337
003 DE-He213
005 20210716111903.0
006 m d
007 cr nn 008maaau
008 211207s2021 sz s 0 eng d
020 $a 9783030728304 $q (electronic bk.)
020 $a 9783030728298 $q (paper)
024 7 $a 10.1007/978-3-030-72830-4 $2 doi
035 $a 978-3-030-72830-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.E55 $b N48 2021
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.9944 $2 23
090 $a RC280.E55 $b N494 2021
245 0 0 $a Neuroendocrine neoplasia management $h [electronic resource] : $b new approaches for diagnosis and treatment / $c edited by Giordano Beretta ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xiv, 331 p. : $b ill., digital ; $c 24 cm.
505 0 $a Part-1: General. History of Neuroendocrine Neoplasia -- Epidemiology of neuroendocrine neoplasms. Part-2: Diagnosis. New concepts in patholog -- Molecular Biology of Neuroendocrine Tumors -- Circulating biochemical markers of gastro-entero-pancreatic (GEP) neuroendocrine neoplasms (NENs) -- Advances in diagnostic imaging. Part-3: New Approaches for Treatment. Treatment of NET related symptoms -- New Surgical Strategies -- New approaches in medical therapies -- Loco-regional Therapies of NEN -- Radioreceptor therapy -- NETs of the lung -- Part-4: Treatment of NETs From Different Organ Origin. Gastric Neuroendocrine Tumors -- Treatment of Pancreatic Neurendocrine Tumors -- Treatment of intestinal NETs (including appendix) -- Treatment of NETs from rare origin -- Neuroendocrine Neoplasms with Peculiar Biology and Features: MEN1, MEN2A, MEN2B, MEN4, VHL, NF1. Part-5: NETs with Peculiar Biology and Feature. Mixed Neuroendocrine and Non-Neuroendocrine Neoplasms ( Mi NEN) -- Merkel Cell Carcinoma -- Therapy in poorly differentiated neuroendocrine neoplasms (NEN G3) -- Conclusion:NENs management today looking at the future.
520 $a This book provides the most recent update on the management of neuroendocrine neoplasia (NEN), a term covering all tumors of various organs and/or with a particular histology, including MEN (multiple endocrine neoplasia) related tumors, MiNEN (mixed neuroendocrine-non-neuroendocrine neoplasms), NEC (neuroendocrine carcinoma) and Merkel's carcinoma. NENs are heterogeneous in their biology, clinical presentation and prognosis, showing a great variability in aggressiveness and therapy response. As a result, their treatment is based on a large spectrum of options. The standard therapies are surgery in early disease, various loco-regional procedures in certain conditions and mostly of a palliative nature in metastatic disease. At present, thanks to our increased understanding of molecular signaling pathways, several pharmacological approaches can be used in patients with advanced NENs. Somatostatin analogs display both anti-tumor effects and symptom control. Novel peptide-radio-receptor treatment (PRRT) is used in patients with well differentiated tumors. The agents targeting angiogenesis and/or PI3K/AKT/mTOR pathway, alone or in combination with analogues, have provided encouraging results in advanced disease. The first part of the book focuses on the history, epidemiology and the most relevant scientific achievements, covering the discoveries in genetic and molecular biology, the endoscopic techniques with guided biopsy, and the metabolic imaging with hybrid PET/CT and MRI/CT. It particularly highlights the emerging strategies in therapy, surgery and mini-invasive surgery as well as loco-regional and systemic treatments, including targeted therapy and/or biological therapies. The second part then explores the management of NENs of various anatomical origins and/or with peculiar biology. It describes the range of the current options and the most relevant results from the clinical trials. This informative book provides valuable insights for all those interested in the management of neuroendocrine neoplasia.
650 0 $a Neuroendocrine tumors $x Diagnosis. $3 2153596
650 0 $a Neuroendocrine tumors $x Treatment. $3 2153597
650 1 4 $a Oncology. $3 751006
650 2 4 $a Nuclear Medicine. $3 823642
650 2 4 $a Endocrinology. $3 610914
650 2 4 $a Surgery. $3 707153
700 1 $a Beretta, Giordano. $3 3501419
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-72830-4
950 $a Medicine (SpringerNature-11650)